$0.67
-0.02 (-3.49%)
Open$0.71
Previous Close$0.69
Day High$0.71
Day Low$0.66
52W High$2.56
52W Low$0.47
Volume—
Avg Volume135.5K
Market Cap7.56M
P/E Ratio—
EPS$-0.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,092.2% upside
Current
$0.67
$0.67
Target
$27.92
$27.92
$15.39
$27.92 avg
$30.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 50.08M | 61.42M | 3.60M |
| Net Income | -5,326,642 | -5,879,295 | 438.1K |
| Profit Margin | -10.6% | -10.1% | 12.2% |
| EBITDA | -2,705,313 | -3,151,885 | 810.0K |
| Free Cash Flow | — | — | 302.1K |
| Rev Growth | -18.5% | -18.5% | +16.0% |
| Debt/Equity | — | — | 0.63 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |